Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population‐based series and a randomized phase III study on adjuvant chemotherapy

Current clinical algorithms are unable to precisely predict which colorectal cancer patients would benefit from adjuvant chemotherapy, and there is a need for novel biomarkers to improve the selection of patients. The metastasis‐promoting protein S100A4 predicts poor outcome in colorectal cancer, bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Boye, Kjetil, Jacob, Havjin, Frikstad, Kari‐Anne M., Nesland, Jahn M., Mælandsmo, Gunhild M., Dahl, Olav, Nesbakken, Arild, Flatmark, Kjersti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971912/
https://www.ncbi.nlm.nih.gov/pubmed/27273130
http://dx.doi.org/10.1002/cam4.766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971912/
https://www.ncbi.nlm.nih.gov/pubmed/27273130
http://dx.doi.org/10.1002/cam4.766

Ejemplares similares